| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Biocon Limited (NSE: BIOCON)
BIOCON Technical Analysis
5
| As on 31st Mar 2023 BIOCON SHARE Price closed @ 206.35 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 284.55 & Strong Sell for SHORT-TERM with Stoploss of 229.17 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BIOCONSHARE Price
| Open | 202.60 | Change | Price | % |
| High | 208.20 | 1 Day | 4.75 | 2.36 |
| Low | 202.30 | 1 Week | 7.65 | 3.85 |
| Close | 206.35 | 1 Month | -19.20 | -8.51 |
| Volume | 3884594 | 1 Year | -129.25 | -38.51 |
| 52 Week High 420.30 | 52 Week Low 306.75 | ||||
| BIOCON CURRENT MONTH FUTURE | |||
| Close | 207.50 | ||
| Contracts Traded | 6849400 | ||
| Open Intrest | 33628300 | ||
| Change In O.I | 3.45 % | ||
| Lot Size | 2300 | ||
| BIOCON CURRENT MONTH OPTION | |
| Most Active Call | 210.00 |
| Most Active put | 200.00 |
| Highest O.I Buildup Call | 210.00 |
| Highest O.I Buildup Put | 200.00 |
| Expiry Date | 2023-04-27 |
| BIOCON ALL MONTHS OPTIONS | |||
| For All BIOCON Options Click Here | |||
NSE INDIA Most Active Stocks
| BCG | 14.60 | 9.77% |
| IDEA | 5.80 | -1.69% |
| YESBANK | 15.05 | 0.67% |
| BEL | 97.55 | 6.55% |
| SOUTHBANK | 14.65 | 1.74% |
| GTLINFRA | 0.70 | 7.69% |
| SUZLON | 7.90 | -0.63% |
| ZOMATO | 51.00 | -0.49% |
| JPPOWER | 5.55 | -0.89% |
| VEDL | 274.45 | -2.59% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
| BIOCON Daily Charts |
BIOCON Intraday Charts |
Whats New @ Bazaartrend |
BIOCON Free Analysis |
|
|
BIOCON Important Levels Intraday
| RESISTANCE | 217.72 |
| RESISTANCE | 214.07 |
| RESISTANCE | 211.82 |
| RESISTANCE | 209.57 |
| SUPPORT | 203.13 |
| SUPPORT | 200.88 |
| SUPPORT | 198.63 |
| SUPPORT | 194.98 |
BIOCON Target March 2023
| 4th UP Target | 337.5 |
| 3rd UP Target | 306.13 |
| 2nd UP Target | 286.75 |
| 1st UP Target | 267.36 |
| 1st DOWN Target | 212.04 |
| 2nd DOWN Target | 192.65 |
| 3rd DOWN Target | 173.27 |
| 4th DOWN Target | 141.9 |
BIOCON Weekly Target
| 4th UP Target | 264.41 |
| 3rd UP Target | 243.34 |
| 2nd UP Target | 230.31 |
| 1st UP Target | 217.28 |
| 1st DOWN Target | 180.12 |
| 2nd DOWN Target | 167.09 |
| 3rd DOWN Target | 154.06 |
| 4th DOWN Target | 132.99 |
BIOCON Target2023
| 4th UP Target | 555.62 |
| 3rd UP Target | 461.41 |
| 2nd UP Target | 403.17 |
| 1st UP Target | 344.94 |
| 1st DOWN Target | 178.76 |
| 2nd DOWN Target | 120.53 |
| 3rd DOWN Target | 62.29 |
| 4th DOWN Target | -31.92 |
Biocon Limited ( NSE INDIA Symbol : BIOCON )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BIOCON Synopsis Technicals View
| 50 Day EMA |
Close is Below EMA 50 (Short Term) |
Bearish | |
| 100 Day EMA | Close is Below EMA 100 (Mid Term) | Bearish | |
| 200 Day EMA | Close is Below EMA 200 (Long Term) | Bearish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is 31.99 | Sideways | |
| MFI (14) | MFI is 27.32 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Short Sell | 304.02 | |
| 10 Day Avg Volume | Traded -0.16 % Less then 10 Day Average Volume | ||
BIOCON Other Details
| Segment | EQ | |
| Market Capital | 408504172544.00 | |
| Sector | Healthcare | |
| Industry | Biotechnology | |
| Offical website | > | |
BIOCON Address
 |
||
BIOCON Latest News
BIOCON Business Profile
Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, dermatology, ophthalmology, neurology, rheumatology, and inflammatory diseases. It is also involved in the integrated discovery, development, and manufacturing services for small and large molecules, antibody-drug conjugates, and oligonucleotides. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India. Address: 20th KM, Hosur Road, Bengaluru, India, 560100
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service